{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:40:33Z","timestamp":1760082033387,"version":"build-2065373602"},"reference-count":20,"publisher":"Jaypee Brothers Medical Publishing","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.59556\/japi.73.1041","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:08:45Z","timestamp":1760080125000},"page":"44-46","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation for the Risk of Allergy to COVID-19 Vaccines in People with History of Allergy Diathesis"],"prefix":"10.59556","volume":"73","author":[{"given":"Dhruve","family":"Soni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita C","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nithya J","family":"Gogtay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukant","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milind Y","family":"Nadkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","reference":[{"key":"key20251010070839_B1","unstructured":"World Health Organization. Statement for Healthcare Professionals: How COVID-19 Vaccines are Regulated for Safety and Effectiveness; 2022. Available from: https:\/\/www.who.int\/news\/item\/17-05-2022-statement-for-healthcare-professionals-how-covid-19-vaccines-are-regulated-for-safety-and-effectiveness."},{"issue":"(9):","key":"key20251010070839_B2","doi-asserted-by":"crossref","first-page":"1293\u2013","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study.","volume":"22","author":"Watson","year":"2022;","journal-title":"Lancet Infect Dis"},{"key":"key20251010070839_B3"},{"key":"key20251010070839_B4"},{"key":"key20251010070839_B5","doi-asserted-by":"crossref","first-page":"868\u2013","DOI":"10.1016\/j.jaci.2015.07.048","article-title":"Risk of anaphylaxis after vaccination in children and adults.","volume":"137:","author":"McNeil","year":"2016;","journal-title":"J Allergy Clin Immunol"},{"key":"key20251010070839_B6","doi-asserted-by":"crossref","first-page":"1533\u2013","DOI":"10.1016\/j.jaip.2018.12.003","article-title":"Immediate hypersensitivity to polyethylene glycols and polysorbates: more common than we have recognized.","volume":"7:","author":"Stone","year":"2019;","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"(4):","key":"key20251010070839_B7","doi-asserted-by":"crossref","first-page":"1423\u2013","DOI":"10.1016\/j.jaip.2020.12.047","article-title":"mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach.","volume":"9","author":"Banerji","year":"2021;","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"(10):","key":"key20251010070839_B8","first-page":"11\u2013","article-title":"Evaluation of allergic reactions following COVID-19 vaccination in patients with documented allergies.","volume":"69","author":"Shukla","year":"2021;","journal-title":"J Assoc Physicians India"},{"issue":"(6):","key":"key20251010070839_B9","doi-asserted-by":"crossref","first-page":"2476\u2013","DOI":"10.1016\/j.jaip.2021.03.022","article-title":"Nonirritant concentrations for skin testing with SARS-CoV-2 mRNA vaccine.","volume":"9","author":"Marcelino","year":"2021;","journal-title":"J Allergy Clin Immunol Pract"},{"key":"key20251010070839_B10","unstructured":"Philippine Society of Allergy, Asthma and Immunology. Assessment of Risk for Allergic Reaction to the Covid-19 Vaccine; 2024. Available from: https:\/\/psaai.org\/."},{"key":"key20251010070839_B11","unstructured":"Practo. Laxopeg Sachet Info; 2022. Available from: https:\/\/www.practo.com\/medicine-info\/laxopeg-sachet-47108."},{"key":"key20251010070839_B12"},{"key":"key20251010070839_B13","unstructured":"SII. ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant). Available from: https:\/\/www.seruminstitute.com\/pdf\/covishield_ChAdOx1_nCoV19_corona_virus_vaccine_insert.pdf."},{"key":"key20251010070839_B14","first-page":"57\u2013","article-title":"Polyethylene glycols (PEGs) and the pharmaceutical industry.","volume":"1:","author":"Henning","year":"2002;","journal-title":"Fine Spl Perform Chem"},{"issue":"(10):","key":"key20251010070839_B15","doi-asserted-by":"crossref","first-page":"3546\u2013","DOI":"10.1016\/j.jaip.2021.06.006","article-title":"The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach.","volume":"9","author":"Greenhawt","year":"2021;","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"(9):","key":"key20251010070839_B16","doi-asserted-by":"crossref","first-page":"2239\u2013","DOI":"10.1007\/s11095-016-1961-x","article-title":"The mystery of antibodies against polyethylene glycol (PEG)\u2014what do we know?","volume":"33","author":"Lubich","year":"2016;","journal-title":"Pharm Res"},{"issue":"(1):","key":"key20251010070839_B17","doi-asserted-by":"crossref","first-page":"3.","DOI":"10.1186\/2045-7022-3-3","article-title":"The skin prick test\u2014European standards.","volume":"3","author":"Heinzerling","year":"2013;","journal-title":"Clin Transl Allergy"},{"issue":"(2):","key":"key20251010070839_B18","doi-asserted-by":"crossref","first-page":"180\u2013","DOI":"10.18176\/jiaci.0683","article-title":"Safety of new mRNA vaccines against COVID-19 in severely allergic patients.","volume":"31","author":"Rojas-P\u00e9rez-Ezquerra","year":"2021;","journal-title":"J Investig Allergol Clin Immunol"},{"key":"key20251010070839_B19","doi-asserted-by":"crossref","first-page":"bcr0220125797.","DOI":"10.1136\/bcr.02.2012.5797","article-title":"Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80.","volume":"2012:","author":"Badiu","year":"2012;","journal-title":"BMJ Case Rep"},{"key":"key20251010070839_B20","doi-asserted-by":"crossref","first-page":"93\u2013","DOI":"10.4103\/picr.PICR_97_19","article-title":"A survey of knowledge and variables influencing perceptions about clinical research: a cross-sectional study from Mumbai.","volume":"12:","author":"Figer","year":"2021;","journal-title":"Perspect Clin Res"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:08:52Z","timestamp":1760080132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.japi.org\/article\/japi-73-7-44"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.59556\/japi.73.1041"],"URL":"https:\/\/doi.org\/10.59556\/japi.73.1041","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}